$3.845
+0.097 (+2.53%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de VNDA por análisis de gráficos similares
Alphio's VNDA stock price prediction model matches the current Vanda Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.80 (-1.30%). The 1-week path is $3.70 (-3.81%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Vanda Pharmaceuticals Inc?
Vanda Pharmaceuticals Inc is currently priced at $3.88, which is significantly below its 52-week high of $9.94, indicating potential upside. However, the stock has a low RSI of 35.207, suggesting it is oversold, but the forward P/E ratio is high at 103.09, indicating that the stock may be overvalued based on future earnings expectations. The recent insider selling has increased by 972.59%, which raises concerns about the company's outlook. Therefore, while there is potential for recovery, the risks associated with high valuation and insider selling suggest a hold position for now.
VNDA cerró en $3.85 el Wednesday, tras subir +2.53%
Vanda Pharmaceuticals Inc (VNDA) last closed at $3.845, gaining +2.53%. These facts feed the 1-day and 1-week VNDA price prediction above.
Consenso de analistas
Vanda Pharmaceuticals Inc (VNDA): 5 comprar, 0 mantener, 1 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Vanda Pharmaceuticals Inc (VNDA) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de VNDA, ordenadas por similitud.
Análisis de estacionalidad de VNDA
Historically the probability of a positive November return for VNDA is 62.79%. December offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de VNDA
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $4.91 | $6.02 | $7.09 | +56.66% |
| Dec 2026 | $4.78 | $5.69 | $6.72 | +48.00% |
En 2026, se proyecta que Vanda Pharmaceuticals Inc (VNDA) oscile entre $4.78 y $7.09.
Previsión mensual de Vanda Pharmaceuticals Inc para 2026
En Nov de 2026, se proyecta que Vanda Pharmaceuticals Inc promedie $6.02, con un mínimo de $4.91 y un máximo de $7.09.
En Dec de 2026, se proyecta que Vanda Pharmaceuticals Inc promedie $5.69, con un mínimo de $4.78 y un máximo de $6.72.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.